Filing Details
- Accession Number:
- 0001140361-11-037172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-18 13:00:00
- Reporting Period:
- 2011-07-15
- Filing Date:
- 2011-07-18
- Accepted Time:
- 2011-07-18 17:34:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184151 | R Conan Deady | One Idexx Drive Westbrook ME 04092 | Corp Vp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-15 | 16,029 | $41.94 | 35,376 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-07-15 | 3,609 | $53.31 | 38,985 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-07-15 | 362 | $56.95 | 39,347 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-15 | 20,000 | $78.37 | 19,347 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-15 | 16,029 | $0.00 | 16,029 | $41.94 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-15 | 3,609 | $0.00 | 3,609 | $53.31 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-15 | 362 | $0.00 | 362 | $56.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,704 | 2014-02-13 | No | 4 | M | Direct | |
| 12,559 | 2017-02-13 | No | 4 | M | Direct | |
| 15,125 | 2015-02-13 | No | 4 | M | Direct |
Footnotes
- The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/09/2011.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $78.3874 to $78.08, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, 3,870 shares on 02/14/2011 and the remaining 1,704 shares on 02/14/2012.
- Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014 and the remaining 1,733 shares on 02/14/2015.
- Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.
Billionaire Hedge Funds
